Skip to content
DataLookout
Menu

HISTORIXNCT05575024

Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 2 words Show 4 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Jun 30, 2026 to Dec 26, 2025
    • Study completion date changed from estimate of Dec 31, 2026 to Dec 31, 2025
    • Site details revised
  2. Notable Primary completion date: Oct 31, 2024 to Jun 30, 2026
    • Study completion date: Dec 31, 2024 to Dec 31, 2026
    v7
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v6
  4. Notable Start date: Jul 1, 2023 to Jan 1, 2024v5
  5. Notable Start date: Feb 1, 2023 to Jul 1, 2023v4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Start date: Dec 1, 2022 to Feb 1, 2023v3
  2. Notable Eligibility criteria revised
    • Primary endpoints revised (2)
    v2
  1. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Rate of all-cause mortality
Timeframe: 28 days
Occurrence rates of ventricular tachycardia, intradialytic hypotension
Timeframe: 28 days

Arms and interventions

Septic AKI

Patients with septic acute kidney injury requiring continuous renal replacement therapy

Devices: oXiris membrane, Polysulfone membrane

Sites

1 site in 1 country

  • Seoul National University HospitalSeoul, South Korea